Development of a prominent granulomatous eruption after interferon-gamma therapy in a patient with mycosis fungoides.
Haruyama
Sanehito
S
Sugita
Kazunari
K
Kawakami
Chika
C
Nakamura
Motonobu
M
Tokura
Yoshiki
Y
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001706:Biopsy; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology* / Q000473:pathology; D005145:Face; D005260:Female; D006099:Granuloma / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D007371:Interferon-gamma / Q000009:adverse effects*; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D016896:Treatment Outcome; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D018926:Anti-Allergic Agents; D000970:Antineoplastic Agents; D062367:ortho-Aminobenzoates; D007371:Interferon-gamma; C012293:tranilast